19th Future Directions in Urology Symposium:
Directions for the Next Generation of Treatments
Agenda
Saturday | August 11, 2018
Location: Robert Trent Jones, Sr. Room, Unless Otherwise Noted
| 4:00-4:10 PM | Welcome/Overview of FDUS Think Tank Presented by Grand Rounds in Urology Program Director: E. David Crawford, MD |
4:10-6:45 PM |
Session 1: Next Generation Developments in Bladder Cancer
|
| 4:10-4:20 PM | Updates in Non-Muscle Invasive Bladder Cancer
Michael S. Cookson, MD |
| 4:20-4:25 PM | Discussion |
| 4:25-4:35 PM | Controversies in Non-Muscle Invasive Bladder Cancer
Siamak Daneshmand, MD |
| 4:35-4:40 PM | Discussion |
| 4:40-4:50 PM | Updates in Immunotherapy for Bladder Cancer
Daniel P. Petrylak, MD |
| 4:50-4:55 PM | Discussion |
| 4:55-5:05 PM | Controversies in Muscle Invasive Bladder Cancer
Sam S. Chang, MD, MBA |
| 5:05-5:10 PM |
Discussion
|
| 5:10-6:15 PM | Bladder Cancer Panel Discussion
Panelists: Chang, Cookson, Daneshmand, Petrylak, Yu |
| 6:15-6:45 PM | State-of-the-Art 10-minute Presentations from Industry Partners
*TBD* |
| 7:00-8:00 PM | Welcome Reception
*Donald Ross Room |
Sunday| August 12, 2018
Location: Robert Trent Jones, Sr. Room, Unless Otherwise Noted
| Morning | OPEN |
2:00-3:00 PM |
Session 2: Next Generation Developments in GU CancersModerator: Daniel P. Petrylak, MD |
| 2:00-2:10 PM | Updates on Renal Cancer
Daniel P. Petrylak, MD |
| 2:10-2:15 PM | Discussion |
| 2:15-2:25 PM | Updates on Upper Track Cancers Raoul S. Concepcion, MD, FACS |
| 2:25-2:30 PM | Discussion |
| 2:30-2:50 PM | GU Cancers Panel Discussion
Panelists: Petrylak, Daneshmand, Cookson, Reiter, Chang, Yu |
| 2:50-3:20 PM | State-of-the-Art 10-minute Presentations from Industry Partners
TBD |
| 3:20-4:15 PM |
Session 3: Next Generation General Urology and Men’s HealthModerator: Mohit Khera, MD, MBA, MPH |
| 3:20-3:30 PM | Controversies in Testosterone Replacement Therapy
Mohit Khera, MD, MBA, MPH |
| 3:30-3:35 PM | Discussion |
| 3:35-3:45 PM | Updates on Nocturia
Matt T. Rosenberg, MD |
| 3:45-3:50 PM | Discussion |
| 3:50-4:20 PM | State-of-the-Art 10-minute Presentations from Industry Partners
TBD |
| 4:20-4:30 PM | Coffee Break |
| 4:30-6:30 PM |
Session 4: Next Generation in BiomarkersModerator: M. Scott Lucia, MD |
| 4:30-4:40 PM | Updates on Screening for Prostate Cancer
Gerald L. Andriole, Jr., MD |
| 4:40-4:45 PM | Discussion |
| 4:45-4:55 PM | Genomic Markers and DNA Sequencing Testing
Daniel W. Lin, MD |
| 4:55-5:00 PM | Discussion |
| 5:00-5:10 PM | Updates on Screening for Bladder Cancer
Michael S. Cookson, MD |
| 5:10-5:15 PM | Discussion |
| 5:15-5:25 PM | The Role of Genetic Testing Risk Assessment
Leonard G. Gomella, MD, FACS |
| 5:25-5:30 PM | Discussion |
| 5:30-6:00 PM | State-of-the-Art 10-minute Presentations from Industry Partners
TBD |
| 6:00-7:00 PM | Concurrent Panel Discussion Breakout Sessions
Screening and Biomarkers Panel Discussion Panelists: Lucia, Crawford, Andriole, Gomella, Yu, Chang General Urology and Men’s Health Panel Discussion Panelists: Khera, Vestal, Kapoor, Langford, Woo |
| Evening | Attendees On Own |
*7:30-9:30 PM Faculty Only Dinner – Play at The Broadmoor
Supported by MDxHealth*
Monday| August 13, 2018
Location: Robert Trent Jones, Sr. Room, Unless Otherwise Noted
| 6:30-7:00 AM | Continental Breakfast |
| 7:00-8:45 AM |
Session 5: Next Generation Imaging in Localized Prostate CancerModerator: Philip J. Koo, MD |
| 7:00-7:10 AM | Next Generation Imaging: Review of RADAR 3
E. David Crawford, MD |
| 7:10-7:15 AM | Discussion |
| 7:15-7:25 AM | Beyond MRI: New Imaging Modalities in Prostate Cancer
Robert E. Reiter, MD |
| 7:25-7:30 AM | Discussion |
| 7:30-7:40 AM | Emerging Indications for a Novel Absorbable Hydrogel Spacer
Steven M. Finkelstein, MD, FACRO |
| 7:40-7:45 AM | Discussion |
| 7:45-7:55 AM | Brachytherapy, MRI-Guided Biopsies, and Post-Radiation Treatments Peter M. Pinto, MD |
| 7:55-8:00 AM | Discussion |
| 8:00-8:10 AM | Next Generation Brachytherapy for Ablation
Thomas J. Pugh, MD |
| 8:10-8:15 AM | Discussion |
| 8:15-8:45 AM | Localized Prostate Cancer Panel Discussion
Panelists: Cookson, Koo, Reiter, Finkelstein, Pinto, Davis, Pugh, Moran |
| 8:45-9:05 AM | State-of-the-Art 10-minute Presentations from Industry Partners
TBD |
| 9:05-10:30 AM |
Session 6: Next Generation Therapeutic Layering and SequencingModerator: Leonard G. Gomella, MD, FACS |
| 9:25-9:35 AM | Use of Radiopharmaceuticals: Updates on Ongoing Clinical Trials
Philip J. Koo, MD |
| 9:35-9:40 AM | Discussion |
| 9:40-9:50 AM | 2019 Proposed Medicare Physician Fee Schedule: Good or Bad for Urology? Deepak Kapoor, MD |
| 9:50-10:00 AM | The Utilization and Value of Using Advanced Practice Providers in Urology Timothy D. Langford, MD |
| 10:00-10:05 AM | Discussion |
| 10:05-10:15 AM | Therapeutic Layering and Sequencing Panel Discussion
Panelists: Gomella, Concepcion, Koo, Yu, Andriole, Goodson, Langford, Kapoor |
| 10:15 AM | ADJOURN FOR MORNING – LUNCH ON OWN |
| 10:15-4:30 PM | OPEN |
| 4:30-5:30 PM |
Session 7: Next Generation Advanced and Castration-Resistant
|
| 4:30-4:50 PM | Point-Counterpoint: The Optimal Nadir T Level on ADT Is >20mg/mL
E. David Crawford, MD Discussants: Timothy Langford, MD and Michael Cookson, MD |
| 4:50-4:55 PM | Targeting the Androgen Receptor: Implications and Resistance Raoul S. Concepcion, MD, FACS |
| 4:55-5:05 PM | The Role of Targeting DNA Repair with PARP Inhibitors
Daniel P. Petrylak, MD |
| 5:05-5:10 PM | Discussion |
| 5:10-5:20 PM | Immunotherapy Updates in Prostate Cancer
Daniel P. Petrylak, MD |
| 5:20-5:25 PM | Discussion |
| 5:25-5:35 PM | Next Generation Anti-Androgen Therapies
Evan Y. Yu, MD |
| 5:35-5:40 PM | Discussion |
| 5:40-6:00 PM | Advanced and CRPC Panel Discussion
Panelists: Yu, Petrylak, Concepcion, Crawford, Gomella, Vestal, Lin, Chang, Cookson |
| 6:00-6:50 PM | State-of-the-Art 10-minute Presentations from Industry Partners
TBD |
| 7:00-8:00 PM | Cocktail Reception *Pompeiian Room* |
| 8:00-10:00 PM | Group Dinner with Guest speaker *Main Ballroom* |
Tuesday| August 14, 2018
Location: Robert Trent Jones, Sr. Room, Unless Otherwise Noted
| 7:00-8:00 AM | Continental Breakfast |
| 7:00-10:00 AM |
Session 7: Next Generation Consensus Development Panels for
|
| 7:00-7:20 AM | Next Generation Bladder and Other GU Cancer Panel Summaries
Daniel P. Petrylak, MD and Michael S. Cookson, MD |
| 7:20-7:40 AM | Next Generation Men’s Health Panel Summary
Gerald L. Andriole, Jr., MD and J. Clifton Vestal, MD |
| 7:40-8:00 AM | Next Generation Biomarker/Sequencing Panel Summaries
Daniel W. Lin, MD and Leonard G. Gomella, MD, FACS |
| 8:00-8:20 AM | Next Generation Imaging in Localized PCa Panel Summary
John M. Davis, MD, FACS and Steven E. Finkelstein, MD, FACRO |
| 8:20-8:40 AM | Next Generation Advanced and ERPC Panel Summary
Evan Y. Yu, MD and Raoul S. Concepcion, MD, FACS |
| 8:40-10:00 AM | Group Panel Discussion Future Directions in Urology: Where Is the Practice of Urology Headed in 5 Years? |
| 10:00 AM |
ADJOURN |